Bessemer Group’s Tandem Diabetes Care TNDM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $467K | Buy |
25,046
+2,537
| +11% | +$47.3K | ﹤0.01% | 841 |
|
|
2025
Q1 | $431K | Sell |
22,509
-15
| -0.1% | -$287 | ﹤0.01% | 912 |
|
|
2024
Q4 | $811K | Buy |
22,524
+297
| +1% | +$10.7K | ﹤0.01% | 800 |
|
|
2024
Q3 | $942K | Buy |
22,227
+167
| +0.8% | +$7.08K | ﹤0.01% | 789 |
|
|
2024
Q2 | $888K | Buy |
22,060
+1,760
| +9% | +$70.8K | ﹤0.01% | 679 |
|
|
2024
Q1 | $719K | Buy |
20,300
+150
| +0.7% | +$5.31K | ﹤0.01% | 730 |
|
|
2023
Q4 | $596K | Buy |
20,150
+5,080
| +34% | +$150K | ﹤0.01% | 776 |
|
|
2023
Q3 | $313K | Buy |
15,070
+6,426
| +74% | +$133K | ﹤0.01% | 930 |
|
|
2023
Q2 | $212K | Buy |
+8,644
| New | +$212K | ﹤0.01% | 1032 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 2160 |
|
|
2022
Q4 | – | Sell |
-53
| Closed | -$3K | – | 2214 |
|
|
2022
Q3 | $3K | Buy |
53
+18
| +51% | +$1.02K | ﹤0.01% | 1870 |
|
|
2022
Q2 | $2K | Hold |
35
| – | – | ﹤0.01% | 1773 |
|
|
2022
Q1 | $4K | Buy |
35
+5
| +17% | +$571 | ﹤0.01% | 1625 |
|
|
2021
Q4 | $5K | Buy |
+30
| New | +$5K | ﹤0.01% | 1596 |
|
|
2020
Q2 | – | Sell |
-7,157
| Closed | -$461K | – | 1808 |
|
|
2020
Q1 | $461K | Buy |
+7,157
| New | +$461K | ﹤0.01% | 803 |
|
|
2018
Q2 | – | Sell |
-157
| Closed | -$1K | – | 1798 |
|
|
2018
Q1 | $1K | Buy |
+157
| New | +$1K | ﹤0.01% | 1662 |
|
|
2015
Q3 | – | Sell |
-8
| Closed | -$1K | – | 1747 |
|
|
2015
Q2 | $1K | Buy |
+8
| New | +$1K | ﹤0.01% | 1465 |
|